Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 15-Jun-12 4:54 PM View:  | Drazba Brian G. VP, Finance & CAO | ISTA Pharmaceuticals Inc. (ISTA) | 06-Jun-12 | Disposition | 40,487 | $9.10 | $368,432.00 | (100%) 40.49K to 0 | |
| 15-Jun-12 5:01 PM View: | Anido Vicente Jr President & CEO Director | ISTA Pharmaceuticals Inc. (ISTA) | 06-Jun-12 | Disposition | 737,116 | $9.10 | $6,707,760.00 | (100%) 737.12K to 0 | |
| 15-Jun-12 4:51 PM View: | Garrett Marvin J Vice President, QC, Compliance | ISTA Pharmaceuticals Inc. (ISTA) | 06-Jun-12 | Disposition | 155,777 | $9.10 | $1,417,570.00 | (100%) 155.78K to 0 | |
| 15-Jun-12 5:00 PM View: | McMullin Kirk VP, Operations | ISTA Pharmaceuticals Inc. (ISTA) | 06-Jun-12 | Disposition | 122,339 | $9.10 | $1,113,280.00 | (100%) 122.34K to 0 | |
| 15-Jun-12 5:01 PM View: | Anido Vicente Jr President & CEO Director | ISTA Pharmaceuticals Inc. (ISTA) | 06-Jun-12 | Option Exercise | 200,000 | $3.24 | $647,906.00 | 37% 537.12K to 737.12K | |
| 15-Jun-12 4:55 PM View: | Williams Richard C Director | ISTA Pharmaceuticals Inc. (ISTA) | 06-Jun-12 | Disposition | 116,032 | $9.10 | $1,055,890.00 | (100%) 116.03K to 0 | |
| 15-Jun-12 4:55 PM View: | Davis Glenn Eugene VP Legal, Chief Compl. Officer | ISTA Pharmaceuticals Inc. (ISTA) | 06-Jun-12 | Disposition | 29,205 | $9.10 | $265,766.00 | (100%) 29.2K to 0 | |
| 15-Jun-12 4:52 PM View: | McGraw Benjamin F III Director | ISTA Pharmaceuticals Inc. (ISTA) | 06-Jun-12 | Disposition | 6,432 | $9.10 | $58,531.20 | (100%) 6.43K to 0 | |
| 15-Jun-12 4:51 PM View: | Mitchell Dean J Director | ISTA Pharmaceuticals Inc. (ISTA) | 06-Jun-12 | Disposition | 4,932 | $9.10 | $44,881.20 | (100%) 4.93K to 0 | |
| 15-Jun-12 4:53 PM View: | Mitro Thomas A VP, Sales & Marketing | ISTA Pharmaceuticals Inc. (ISTA) | 06-Jun-12 | Disposition | 161,169 | $9.10 | $1,466,640.00 | (100%) 161.17K to 0 | |
| 15-Jun-12 5:03 PM View: | McGinley Kathleen VP, HR and Corp. Services | ISTA Pharmaceuticals Inc. (ISTA) | 06-Jun-12 | Disposition | 97,508 | $9.10 | $887,323.00 | (100%) 97.51K to 0 | |
| 15-Jun-12 4:53 PM View: | Silvernail Lauren P CFO & VP Corporate Development | ISTA Pharmaceuticals Inc. (ISTA) | 06-Jun-12 | Disposition | 187,141 | $9.10 | $1,702,980.00 | (100%) 187.14K to 0 | |
| 15-Jun-12 5:02 PM View: | McNamara Timothy VP Clinical Research & Medical | ISTA Pharmaceuticals Inc. (ISTA) | 06-Jun-12 | Disposition | 90,754 | $9.10 | $825,861.00 | (100%) 90.75K to 0 | |
| 15-Jun-12 5:02 PM View: | Hutt Peter Barton Director | ISTA Pharmaceuticals Inc. (ISTA) | 06-Jun-12 | Disposition | 4,932 | $9.10 | $44,881.20 | (100%) 4.93K to 0 | |
| 15-Jun-12 5:01 PM View: | Roe Wayne I Director | ISTA Pharmaceuticals Inc. (ISTA) | 06-Jun-12 | Disposition | 38,558 | $9.10 | $350,878.00 | (100%) 38.56K to 0 | |
| 15-Jun-12 4:56 PM View: | Perlman Andrew J Director | ISTA Pharmaceuticals Inc. (ISTA) | 06-Jun-12 | Disposition | 4,932 | $9.10 | $44,881.20 | (100%) 4.93K to 0 | |
| 23-May-12 7:34 PM View: | Mitro Thomas A VP, Sales & Marketing | ISTA Pharmaceuticals Inc. (ISTA) | 22-May-12 | Payment of Exercise | 70,837 | $9.08 | $643,200.00 | (31%) 232.01K to 161.17K | 0% |
| 23-May-12 7:34 PM View: | Mitro Thomas A VP, Sales & Marketing | ISTA Pharmaceuticals Inc. (ISTA) | 22-May-12 | Option Exercise | 116,804 | $5.51 | $643,193.00 | 101% 115.2K to 232.01K | |
| 22-May-12 8:01 PM View: | McNamara Timothy VP Clinical Research & Medical | ISTA Pharmaceuticals Inc. (ISTA) | 18-May-12 | Option Exercise | 80,669 | $5.02 | $405,144.00 | 147% 54.75K to 135.42K | |
| 22-May-12 8:01 PM View: | McNamara Timothy VP Clinical Research & Medical | ISTA Pharmaceuticals Inc. (ISTA) | 18-May-12 | Payment of Exercise | 44,668 | $9.07 | $405,139.00 | (33%) 135.42K to 90.75K | (< 1%) |
| 21-May-12 8:01 PM View: | Garrett Marvin J Vice President, QC, Compliance | ISTA Pharmaceuticals Inc. (ISTA) | 17-May-12 | Payment of Exercise | 81,802 | $9.06 | $741,126.00 | (34%) 237.58K to 155.78K | (< 1%) |
| 21-May-12 8:02 PM View: | McMullin Kirk VP, Operations | ISTA Pharmaceuticals Inc. (ISTA) | 17-May-12 | Option Exercise | 108,943 | $4.90 | $533,997.00 | 151% 72.33K to 181.28K | |
| 21-May-12 8:01 PM View: | Garrett Marvin J Vice President, QC, Compliance | ISTA Pharmaceuticals Inc. (ISTA) | 17-May-12 | Option Exercise | 174,778 | $4.24 | $741,120.00 | 278% 62.8K to 237.58K | |
| 21-May-12 8:02 PM View: | McMullin Kirk VP, Operations | ISTA Pharmaceuticals Inc. (ISTA) | 17-May-12 | Payment of Exercise | 58,939 | $9.06 | $533,987.00 | (33%) 181.28K to 122.34K | (< 1%) |
| 14-May-12 8:07 PM View: | McGinley Kathleen VP, HR and Corp. Services | ISTA Pharmaceuticals Inc. (ISTA) | 10-May-12 | Payment of Exercise | 40,927 | $9.09 | $372,026.00 | (30%) 137.73K to 96.81K | 0% |
| 14-May-12 8:07 PM View: | McGinley Kathleen VP, HR and Corp. Services | ISTA Pharmaceuticals Inc. (ISTA) | 10-May-12 | Option Exercise | 77,881 | $4.78 | $372,037.00 | 130% 59.85K to 137.73K | |
| 10-May-12 9:18 PM View: | Silvernail Lauren P Chief Financial Officer | ISTA Pharmaceuticals Inc. (ISTA) | 08-May-12 | Payment of Exercise | 80,577 | $9.08 | $731,639.00 | (30%) 265.6K to 185.02K | < 1% |
| 10-May-12 9:17 PM View: | Anido Vicente Jr President & CEO Director | ISTA Pharmaceuticals Inc. (ISTA) | 08-May-12 | Payment of Exercise | 46,091 | $9.08 | $418,506.00 | (8%) 587.21K to 541.12K | < 1% |
| 10-May-12 9:19 PM View: | Drazba Brian G. VP, Finance & CAO | ISTA Pharmaceuticals Inc. (ISTA) | 08-May-12 | Payment of Exercise | 14,172 | $9.08 | $128,682.00 | (26%) 54.66K to 40.49K | < 1% |
| 10-May-12 9:18 PM View: | Silvernail Lauren P Chief Financial Officer | ISTA Pharmaceuticals Inc. (ISTA) | 08-May-12 | Option Exercise | 145,813 | $5.02 | $731,653.00 | 122% 119.78K to 265.6K | |
| 10-May-12 9:19 PM View: | Drazba Brian G. VP, Finance & CAO | ISTA Pharmaceuticals Inc. (ISTA) | 08-May-12 | Option Exercise | 33,283 | $3.87 | $128,680.00 | 156% 21.38K to 54.66K | |
| 10-May-12 9:17 PM View: | Anido Vicente Jr President & CEO Director | ISTA Pharmaceuticals Inc. (ISTA) | 08-May-12 | Option Exercise | 98,120 | $4.27 | $418,500.00 | 20% 489.09K to 587.21K | |
| 23-Mar-12 4:03 PM View: | Credit Suisse First Boston/ 10% Owner | ISTA Pharmaceuticals Inc. (ISTA) | 21-Mar-12 | Disposition (other) | 674,116 | -- | -- | (15%) 4.47M to 3.8M | |
| 16-Mar-12 4:49 PM View: | Credit Suisse First Boston/ 10% Owner | ISTA Pharmaceuticals Inc. (ISTA) | 15-Mar-12 | Market Sale | 437,245 | $8.56 | $3,742,800.00 | (2%) 23.69M to 23.25M | (< 1%) |
| 16-Mar-12 4:49 PM View: | Credit Suisse First Boston/ 10% Owner | ISTA Pharmaceuticals Inc. (ISTA) | 14-Mar-12 | Market Sale | 28,571 | $8.70 | $248,551.00 | (< 1%) 23.72M to 23.69M | 1% |
| 12-Mar-12 4:03 PM View: | Credit Suisse First Boston/ 10% Owner | ISTA Pharmaceuticals Inc. (ISTA) | 08-Mar-12 | Market Sale | 222,650 | $8.31 | $1,849,660.00 | (1%) 15.1M to 14.88M | (2%) |
| 05-Mar-12 5:15 PM View: | Davis Glenn Eugene VP Legal, Chief Compl. Officer | ISTA Pharmaceuticals Inc. (ISTA) | 01-Mar-12 | Disposition | 1,222 | $8.23 | $10,057.10 | (4%) 29.2K to 27.98K | < 1% |
| 02-Mar-12 5:06 PM View: | Credit Suisse First Boston/ 10% Owner | ISTA Pharmaceuticals Inc. (ISTA) | 29-Feb-12 | Disposition (other) | 1,002,550 | -- | -- | (16%) 6.17M to 5.17M | |
| 09-Feb-12 7:42 PM View: | McGinley Kathleen VP, HR and Corp. Facilities | ISTA Pharmaceuticals Inc. (ISTA) | 08-Feb-12 | Disposition | 837 | $8.15 | $6,821.55 | (1%) 60.69K to 59.85K | 0% |
| 09-Feb-12 7:41 PM View: | Mitro Thomas A VP, Sales & Marketing | ISTA Pharmaceuticals Inc. (ISTA) | 08-Feb-12 | Disposition | 1,327 | $8.15 | $10,815.00 | (1%) 116.53K to 115.2K | 0% |
| 09-Feb-12 7:41 PM View: | McNamara Timothy VP Clinical Research & Medical | ISTA Pharmaceuticals Inc. (ISTA) | 08-Feb-12 | Disposition | 837 | $8.15 | $6,821.55 | (2%) 55.59K to 54.75K | 0% |
| 09-Feb-12 7:43 PM View: | Anido Vicente Jr President & CEO Director | ISTA Pharmaceuticals Inc. (ISTA) | 08-Feb-12 | Disposition | 3,332 | $8.15 | $27,155.80 | (< 1%) 492.42K to 489.09K | 0% |
| 09-Feb-12 7:43 PM View: | Garrett Marvin J Vice President, QC, Compliance | ISTA Pharmaceuticals Inc. (ISTA) | 08-Feb-12 | Disposition | 1,046 | $8.15 | $8,524.90 | (2%) 63.85K to 62.8K | 0% |
| 09-Feb-12 7:41 PM View: | Silvernail Lauren P Chief Financial Officer | ISTA Pharmaceuticals Inc. (ISTA) | 08-Feb-12 | Disposition | 1,066 | $8.15 | $8,687.90 | (< 1%) 120.85K to 119.78K | 0% |
| 09-Feb-12 7:42 PM View: | McMullin Kirk VP, Operations | ISTA Pharmaceuticals Inc. (ISTA) | 08-Feb-12 | Disposition | 836 | $8.15 | $6,813.40 | (1%) 73.17K to 72.33K | 0% |
| 09-Feb-12 7:41 PM View: | Mitro Thomas A VP, Sales & Marketing | ISTA Pharmaceuticals Inc. (ISTA) | 07-Feb-12 | Disposition | 1,167 | $8.17 | $9,534.39 | (< 1%) 117.7K to 116.53K | < 1% |
| 09-Feb-12 7:41 PM View: | McNamara Timothy VP Clinical Research & Medical | ISTA Pharmaceuticals Inc. (ISTA) | 07-Feb-12 | Disposition | 889 | $8.17 | $7,263.13 | (2%) 56.48K to 55.59K | < 1% |
| 09-Feb-12 7:43 PM View: | Anido Vicente Jr President & CEO Director | ISTA Pharmaceuticals Inc. (ISTA) | 07-Feb-12 | Disposition | 3,333 | $8.17 | $27,230.60 | (< 1%) 495.75K to 492.42K | < 1% |
| 09-Feb-12 7:41 PM View: | Silvernail Lauren P Chief Financial Officer | ISTA Pharmaceuticals Inc. (ISTA) | 07-Feb-12 | Disposition | 1,146 | $8.17 | $9,362.82 | (< 1%) 122.0K to 120.85K | < 1% |
| 09-Feb-12 7:42 PM View: | McMullin Kirk VP, Operations | ISTA Pharmaceuticals Inc. (ISTA) | 07-Feb-12 | Disposition | 889 | $8.17 | $7,263.13 | (1%) 74.06K to 73.17K | < 1% |
